RPM-Drive: A robust, safe, and reversible gene drive system that remains
  functional after 200+ generations by Reed, Floyd A. et al.
RPM-Drive: A robust, safe, and reversible gene drive system that remains functional after 
200+ generations 
 
Floyd A. Reed 1,*, Todd G. Aquino-Michaels 2,5, Maria S. Costantini 1,3,5, Áki J. Láruson 1,5, and 
Jolene T. Sutton 4,* 
 
1 Department of Biology, University of Hawai‘i at Mānoa, 2538 McCarthy Mall, Honolulu, HI 
96822  
2 Department of Molecular Biosciences and Bioengineering, University of Hawai‘i at Mānoa, 
3050 Maile Way, Honolulu, HI 96822  
3 Kaua‘i Forest Bird Recovery Project, 3751 Hanapepe Rd., Hanapepe, HI 96716  
4 Department of Biology, University of Hawai‘i at Hilo, 200 W. Kāwili St., Hilo, HI 96720  
 
5 These authors contributed equally to this work 
* Authors for correspondence: floydr@hawaii.edu; jtsutton@hawaii.edu 
 
Key words: 
population alteration; underdominance; haploinsufficient; ribosomal protein genes; genetic pest 
management 
 
Significance 
Fully synthetic gene drive systems are designed to be used for controlling insect-vectored 
diseases, such as malaria and Zika, as well as agricultural pests, and even for conservation 
applications [reviewed in 1-3]. However, despite that several systems now exist in laboratories, 
most suffer limitations that prevent their suitability for real-world applications [e.g., 4-7]. One 
critical limitation is that many systems are predicted or known to experience mutational 
breakdown in relatively few generations, meaning that even if population replacement is 
successful, this success is likely to be short-lived. Here we show that one fully synthetic gene 
drive system, RPM-Drive, is resistant to mutational breakdown and is still effective over very 
many generations. Combined with its additional desirable properties of being reversible, 
geographically stable, and likely to be portable for use in a wide range of species, continued 
research assessing the suitability of RPM-Drive for real-world applications is warranted. 
 
 
Abstract 
 
Despite the advent of several novel, synthetic gene drive mechanisms and their potential to 
one-day control a number of devastating diseases, among other applications, practical use of 
these systems remains contentious and risky. In particular, there is little in the way of empirical 
evidence of the long-term robustness of these synthetic systems against mutational breakdown. 
Rather, most existing systems are either known or predicted to be susceptible to rapid 
inactivation, though methodological designs continue to be refined. Here we evaluate a currently 
existing synthetic, underdominance-based gene drive system 200+ generations after it was first 
established in a laboratory colony of Drosophila melanogaster. Not only do we find that the 
system is still functioning as designed, we also show evidence that disruptions to the genetic 
construct are highly likely to be removed by natural selection, contributing to the system’s 
robust, long-term stability. This stability appears to be a result of a fundamental relationship 
between ribosomal proteins (a novel target of the system) and natural cellular defenses that 
protect against cancer development. As far as we are aware, this is the longest continually 
functioning synthetic gene drive system thus verified, making it highly appropriate for additional 
research into its eventual suitability for field trials. Due to inherent properties of this gene drive, 
it is also likely to be adaptable for use in many different species. The insect lines established and 
used to test this system have been deposited at a Drosophila stock center, and are available to 
labs for further, independent testing. 
 
Introduction 
 
Developing synthetic gene drive systems as a tool to spread a desired gene through a wild 
population has been a research goal for 50 years [8]. Early efforts to engineer gene drive systems 
focused on chromosomal rearrangements that resulted in underdominance (i.e., heterozygotes are 
less fit than either homozygote [e.g., 8, 9]). Because underdominance results in bi-stability, 
whereby an engineered genetic construct only spreads to genotype fixation when it is released 
above an established frequency threshold, underdominance-based gene drive systems are both 
reversible and geographically stable [1, 10-12]. A fully transformed population can be reverted 
back to wildtype if the wildtype allele is released above the frequency threshold (i.e., bi-stable). 
These traits are likely to be highly desirable for practical use [e.g., 1, 13, 14]. Although early 
research into chromosomal rearrangements for generating underdominance resulted in high 
fitness costs that made these systems impractical, in recent years different forms of synthetic 
underdominance-based gene drive systems have been successfully developed in laboratory 
settings [11, 15]. Other recently proposed or developed gene drive systems range from Medea 
maternal effect “poison-rescue” systems [e.g., 16], to targeted DNA double-strand break based 
homology repair-mediated systems [e.g., 17-19]. These and additional systems are reviewed in 
detail elsewhere [e.g., 1, 3, 13]. Crucially, all but one existing synthetic gene drive system [11, 
which we focus on here] has experienced various forms of limitation in terms of potential 
practical use and/or portability to non-model organisms, such as a need for extensive species-
specific genetic knowledge in Medea-type systems (i.e., knowledge of the precise timing and 
control of gene expression during development; [e.g., 15]), and rapid inactivation due to 
mutation in homology repair systems [4, 5, 20]. Before field trials can be considered for any 
synthetic gene drive system, a number of practical and ethical considerations will need to be 
addressed [e.g., 13, 14, 21], among which robustness of the system is critical. 
Here we re-evaluate the haploinsufficiency-based underdominance gene drive system of [11]; 
hereafter referred to as RPM-Drive, for “Ribosomal Protein Minute-Drive” (see below for 
details), and newly test the capacity for mutations to disrupt it. This type of underdominance 
system has already been shown to be safe against unintended establishment in the wild (i.e., 
geographically stable; [10, 12]), reversible [10, 12], and is likely to be widely portable across 
species [11]. A D. melanogaster stock with the RPM-Drive system was generated in the summer 
of 2009, and the results given in [11] were generated during the fall/winter of 2009/2010. The 
stock has been continuously maintained since its establishment, in approximately 20 replicate 
vials with approximately 100 adults per vial. The laboratory work reported here was conducted 
in the fall of 2017, over 200 generations from when the stock was first established (assuming 
approximately 25 generations per year). In re-evaluating this system, we aimed to test how well 
it performs after 200+ generations. To the best of our knowledge, no other synthetic gene drive 
system has proven stable for so long [e.g., 4, 20]. We also conduct novel crosses to infer the 
likely result of mutations inactivating different components of the genetic construct that was 
used to establish this underdominance-based gene drive. 
RPM-Drive utilizes the naturally haploinsufficient properties of ribosomal proteins 
(hereafter, Rp) [11]. Gene expression from only a single copy of a Rp gene results in a loss of 
fitness and delayed development [pp. 206–212 22, 23]. In Drosophila, this is described as a 
“Minute” phenotype. Since their initial characterization [reviewed in 22], Minute-like phenotypes 
resulting from haploinsufficient ribosomal proteins have been reported in many species ranging 
from plants [24] to yeast [25] to fish [26] to mammals [27, 28]. To take advantage of ribosomal 
protein haploinsufficiency, RPM-Drive uses RNA interference (RNAi) mediated knockdown to 
target an endogenouse Rp gene, in this case the D. melanogaster RpL14 (Figure 1) [11]. The 
construct also contains a synthetic “RpL14-rescue”, which performs the same function as the 
endogenous RpL14 (i.e., makes the same protein); however, due to a series of synonymous 
nucleotide substitutions between it and the endogenous gene, the RpL14-rescue is not a target of 
RNAi. The original construct also includes a built-in “failsafe” with the genetic modification: the 
RNAi knockdown is under the control of a balanced recessive lethal GAL4 transactivator on a 
different chromosome [11, 29]. In the event of an accidental release, the gene drive would 
quickly inactivate over the following generations, due to independent assortment of the system 
away from the GAL4 and removal of GAL4 by selection [11]. For actual applications, or for 
RPM-Drive establishment in other organisms, the GAL4 transactivator would not be included in 
the genetic construct. Figure 1 demonstrates how the RPM-Drive construct generates 
underdominance by targeted knockdown and rescue of Rp expression. Altrock et al. [10] further 
describes the evolutionary dynamics of such a system. 
To evaluate the mutational stability of RPM-Drive, we consider both loss-of-function 
mutation (the most frequent class of mutation [e.g., 30]), and gain-of-function mutation 
scenarios: i) The Rp-rescue becomes inactivated; ii) The RNAi knockdown becomes inactivated; 
iii) Both the Rp-rescue rescue and RNAi knockdown become inactivated simultaneously; and iv) 
The endogenous Rp gene (RpL14 in Figure 1) evolves to evade RNAi knockdown. Under these 
scenarios, the final Rp dosages in individuals will be altered from two (fully functional) to zero 
(lethal), one (underexpression; haploinsufficient), or three or greater (overexpression). Since 
scenario iii is already predicted to be removed from the population [see 10, and references 
therein], we do not consider it here for further experimentation, though we do discuss it below. 
With scenarios i, ii, and iv in mind, we conducted three separate experiments aimed to:  
 
1) Re-evaluate the effectiveness of the RPM-Drive system, and thereby compare final Rp 
dosages of two to one. 
2) Test an outcross that disrupts the built-in failsafe (loss-of-function), and thereby compare 
final Rp dosages of one to three. 
3) Test the effects of Rp overexpression via a gain-of-function mutation, and thereby 
compare a final Rp dosage of two to three. 
 
In Experiment 1 we re-evaluate the original RPM-Drive system in the context of how well it 
is functioning 200+ generations since its establishment in a laboratory colony of D. 
melanogaster. In novel Experiments 2 and 3 we evaluate the fitness effects of Rp overexpression. 
Our results show that RPM-Drive has remained stable over the long-term, and is still functioning 
effectively. These results also show that this system is robust against mutations, which are 
efficiently removed by natural selection, due to fitness consequences with either under- or 
overexpression of Rps. We discuss probable reasons behind these fitness consequences in light of 
their implications for the potential practical use of RPM-Drive. 
 
Results 
 
Experiment 1: Evaluate RPM-Drive after 200+ generations (compare Rp dosage of one to 
two) 
To assess the current activity of the RPM-Drive system in a fashion similar to how it was 
originally assessed by [11], we initiated crosses of RPM-Drive / RPM-Drive homozygotes with 
wildtype, + / +  (RPM-Drive initial frequencies = 0.5). These homozygous parental stocks were 
termed F0. We allowed the system to proceed to the F2 generation, at which point genotypes 
were recorded. In the absence of underdominance effects, the expected ratio of genotypes for F2s 
is 1:2:1 per standard Mendelian expectations. A total of 201 F2 offspring were scored (Table S1). 
A significant deviation with fewer than expected hemizygotes was found (a 20.4% relative 
reduction; male and female genotype counts combined, χ2 = 9.567, d.f. = 2, P = 0.0084; exact 
binomial test of π = 0.5 of combined homozygote counts and hemizygote counts, one sided, P = 
0.0023; Figure 2). The average egg-to-adult eclosion development time for male homozygotes 
was 13.831 days. The average male hemizygote development time was 14.483 days, an increase 
of 4.71%. This was assessed with a two-sample Kolmogorov-Smirnov test, and heterozygotes 
were found to have a significantly longer development time (D = 0.312, P = 0.020). The average 
female homozygote development time was 13.464 days. The development time of female 
hemizygotes was 14.353 days, an increase of 6.60%. This was also found to be significant with a 
Kolmogorov-Smirnov test (D = 0.359, P = 0.0010).  
 
Experiment 2: Compare Rp dosage of one to three 
By crossing the homozygous RPM-Drive line (Figure 1, panel A) with another homozygous 
line, w- (white-eyed “wildtype”; Figure 3, panel A ), we produced hemizygous F1 offspring 
either inheriting the GAL4 transactivator, or the Cy- balancer (Figure 3, panels B & C). Offspring 
had Rp dosages of either one (from a single copy of the RpL14-rescue; Figure 3, panel B), or 
three (a single copy of the RpL14-rescue, plus two functioning endogenous RpL14; Figure 3, 
panel C). While there were fewer single Rp dosage (i.e., Cy+ phenotype) offspring in the F1 
generation, the difference was not significant (9.20% relative reduction, male and female 
genotype counts combined, χ2 = 0.723, d.f. = 1, P = 0.395; exact binomial test of π = 0.5 one 
sided, P = 0.214; Figure 4A; Table S2). Relative abundance did not differ among offspring of 
this cross. However, there was a difference in development time (Figure 4B; Table S2). The 
mean male triple Rp dosage (Cy- phenotype) development time was 13.0 days. The mean male 
single Rp dosage (Cy+ phenotype) development time was 13.48 days, an increase of 3.69% 
(Kolmogorov-Smirnov test, D = 0.357, P = 6 × 10-5). The mean female triple Rp dosage (Cy- 
phenotype) time was 12.72 days. The mean female single Rp dosage (Cy+ phenotype) 
development time was 13.29 days, a relative increase of 4.48% (Kolmogorov-Smirnov test, D = 
0.286, P = 0.00156).  
 
Experiment 3: Compare Rp dosage of two to three 
Triple Rp dosage offspring from Experiment 2 did not have a GAL4 transactivator, and 
therefore no RNAi expression, but did contain a single copy of the RpL14-rescue (Cy- phenotype; 
Figure 3, panel C). By crossing these Cy- offspring from Experiment 2 with the homozygous w- 
(white-eyed; Figure 3, panel A), we completely removed the GAL4 transactivator so that the 
dosage of three Rps to two could be compared in F1 offspring (Figure 3, panels D & E). In this 
experiment, the RpL14-rescue insert could be tracked by w+ (red eyes) in an otherwise w- 
background, or by RFP (Figure 3, panel D). There were fewer w+ offspring (87 out of 207; 
Figure 4C; Table S3). This deviation from an expected 1:1 ratio was significant (male and female 
genotype counts combined, χ2= 5.261, d.f. = 1, P = 0.0218; exact binomial test π = 0.5 one sided, 
P = 0.0130). The average development time of w+ males was 14.89 days compared to 14.86 days 
for w- males (Figure 4D; Table S3). The difference was not significant (two-sample 
Kolmogorov-Smirnov test, D = 0.0667, P = 0.9996). The average development time of w+ 
females was 14.83 days compared to 15.04 days for w- females (Figure 4D; Table S3). Again, the 
difference was not significant (two-sample Kolmogorov-Smirnov test, D = 0.1412, P = 0.7755).  
 
Discussion  
 
RPM-Drive is still functioning after 200+ generations 
Experiment 1 replicated the results presented in [11], both in terms of reduced egg-to-adult 
viability and delayed development of RPM-Drive hemizygotes compared to both homozygotes. 
This is consistent with a Minute-like haploinsufficient effect and underdominance, and indicates 
that RPM-Drive is still functioning effectively after 200+ generations, and is therefore robust to 
rapid breakdowns from mutation. Indeed, unlike alternative gene drive methods that rely on 
DNA double-strand breaks and homology directed repair [e.g., 4, 17], there is no a priori reason 
to suspect the RPM-Drive would be particularly susceptible to disruptions by mutation. 
The relative differences for eclosion time between homozygotes and hemizygotes was not 
quite as large in 2017 as it was in 2009/2010 (see Figure S4 in [11]). Our results were a 4.71% 
difference in males, and 6.60% difference in females. The results from [11] were 6.59% in 
males, and 7.33% in females. It is possible that these differences could be due to differences in 
lab environments; alternatively, slightly increased expression of the Rp-rescue could have been 
selected for over time. The multi-generational experiment of [11] estimated lower fitness of 
RPM-Drive homozygotes relative to wildtype. If this were due to lower than optimal expression 
of the Rp-rescue, then selection over 200+ generations may have resulted in increased expression 
of the Rp-rescue, which would reduce the Minute-like fitness cost of the hemizygote. This would 
act to mildly relax the strength of underdominance over time, but is not expected to inactivate 
RPM-Drive (i.e., not expected to inactivate underdominance).  
Both under- and over-expression of Rp result in reduced fitness 
The fitness loss of Rp haploinsufficiency (i.e., underexpression of Rp) is well established in 
the literature [e.g., 22, 24, 27, 31]. The more novel result from this study is the fitness cost of Rp 
overexpression, as evidenced here in Experiment 2 and 3. The most likely explanation for the 
fitness cost that we observed from Rp overexpression is that this cost results from the extra-
ribosomal role of Rps as monitors of genome stability. Rps are under strong expression control in 
order to form fully assembled, functional ribosomes [32]. These Rps are found across the 
genome [22], and may have a range of extra-ribosomal functions including acting as sentinels of 
genome integrity. For example, genome rearrangements, duplications, and deletions are 
associated with carcinogenesis [33]. Because Rps are dispersed across the genome, large 
duplications and deletions are likely to also involve Rp coding genes, resulting in an imbalanced 
complement of ribosome units and an excess of free Rps. This effect could be used as a cell 
signal of genome instability, and trigger cell cycle arrest and cell death pathways to act as a 
multicellular defense against cancer development. Indeed, there are suggestions that this is the 
case, ranging from evidence that Rps also act as tumor suppressors [26, 34], are involved in cell 
cycle checkpoint control [25], and that there are interactions between free Rps and p53, an 
important cell cycle regulator and tumor suppressor [35]. Overexpression of RpL14 in 
Experiment 2 and 3 may lower fitness via this type of mechanism (to have fitness on par with 
Minute-like haploinsufficiency in Experiment 2, and significantly reduced fitness relative to 
balanced Rp expression in Experiment 3. Note that these results are likely to be conservative, 
because our additional Rp insert was marked with w+ in an otherwise w- background. White is an 
important ABC transporter that negatively affects many components of Drosophila fitness when 
inactivated [e.g., 36]; however, the majority of these effects may be post eclosion [37], which 
was not tested here.   
 
RPM-Drive is robust to disruptions by mutation 
In light of our results, it is useful to consider the evolutionary dynamics of a range of simple 
scenarios of mutational disruption to this type of gene drive system (Figure 5). Inactivation of the 
Rp-rescue will result in haploinsufficiency (and lethality when homozygous), and is predicted to 
be removed from the population by selection (Figure 5B). Homozygous inactivation of the RNAi 
knockdown results in an imbalanced excess of Rp production, possibly triggering cell cycle 
arrest and cell death pathways; this is also likely to be removed by selection because of the 
associated fitness cost (Figure 5C). A deletion or inactivation of the entire region essentially 
results in a wildtype allele. If this is a rare allele, say in a population transformed by 
underdominance, it is expected to be removed from the population over the following 
generations (Figure 5D). The endogenous Rp can potentially be inactivated via neutral mutations 
that accumulate in the population (Figure 5E); however, this does not destabilize the population 
transformation system. It is also possible to imagine compound loss of function mutations that 
have a high transient fitness (Figure 5F). However, these genotypes are likely to be broken up in 
the following generations and removed by selection, due to alterations of Rp dosage away from 
wildtype (i.e., lowering fitness), and/or low frequency in combination with no fitness advantage 
(i.e., mutations that result in Rp dosage that is the same as wildtype). Thus, a range of simple 
mutational scenarios are not expected to become established from low frequency. A population 
transformed by RPM-Drive therefore corresponds to an evolutionary Nash equilibrium (no single 
change results in an increase in fitness [38]) or an “evolutionarily stable strategy” [39], and the 
system is expected to be robust to inactivating mutations.  
Several potential directions could further evaluate RPM-Drive. Artificial mutagenesis could 
be used to elevate the mutation rate, to further test how the system might and might not break 
down by mutation. Only simple loss of function mutations were modeled here; however, more 
complex types of mutations might have effects of interest; although these can be harder to 
predict [cf. 40]. It would also be informative to test the fitness effects of different RNAi 
expression patterns beyond the Actin promoter used here. There are a wide range of GAL4 and 
GAL80 Drosophila lines readily available to do this. Now that this RPM-Drive construct has 
been more thoroughly tested and the properties of this gene drive insert are well understood these 
lines have been deposited at the Bloomington Drosophila Stock Center and listed in FlyBase to 
be available to independent labs. We encourage further experimentation by other labs. The 
formalized stock identification and genotypes are:  
 
Bloomingto
n Stock 
Center ID Genotype 
78574 w[*]; Pw[+mC]=Act-GAL425FO1/CyO;M3xP3-GFPZH-86Fb 
78575 w[*]; 
Pw[+mC]=Act5CGAL425FO1/CyO;Mw[+mC]=UASRpL14.dsRNA.RpL14[r]Z
H-86Fb 
 
, where 78574 corresponds to the GFP marked “wildtype” homozygote in Figure 1 and 78575 
corresponds to the RFP marked RPM-Drive modified homozygote in Figure 1. Research 
Resource Identifiers (RRIDs) are: RRID:BDSC_78574 and RRID:BDSC_78575. See 
https://bdsc.indiana.edu/stocks/misc/under_dominant_1.html  
 
Conclusions 
Here we describe a re-assessment of a fully synthetic underdominance-based gene drive 
system, RPM-Drive, 200+ generations after it was first established in a laboratory colony of D. 
melanogaster. We also perform the first novel experiments to disrupt components of the genetic 
construct, and thereby evaluate the robustness of RPM-Drive to mutation, as part of our ongoing 
efforts to assess the practicality of this system for possible future field trials. Our experiments 
confirm that RPM-Drive maintains long-term stability and functionality, and continues to result 
in underdominance due to ubiquitous haploinsufficient properties of ribosomal proteins. 
Hemizygous flies had longer developmental time, and hence reduced fitness, compared with 
either homozygous individuals carrying the genetic modification, or homozygous wildtype 
individuals. It was previously shown with RPM-Drive that transgene removal (i.e., reversibility) 
could be achieved by introducing wildtype alleles at a frequency above the bi-stable equilibrium 
threshold [11]. Due to its practical advantages, RPM-Drive warrants further investigation for 
applications with other organisms. It is likely that due to inherently high threshold frequencies, 
this system will be most useful for populations that are relatively small and/or localized. 
However, for wider applications RPM-Drive could be integrated with additional technologies, to 
synergistically combine the most useful aspects of various approaches. For example, a first 
application of a technology aimed at population suppression, such as an insecticide or sterile-
male strategy, followed by RPM-Drive combined with a specific gene of interest, may rapidly 
and effectively lead to complete, stable population replacement.  
 
Methods 
 
Fly rearing  
Drosophila melanogaster were maintained on standard “cornmeal” media (cornmeal, yeast, 
soy flour, dextrose, sucrose, agar; cf. 
https://bdsc.indiana.edu/information/recipes/bloomfood.html) with tegosept antifungal agent in 
37 mL volume vials at 24 C on a 12:12 light/dark day cycle. The time of adding adults to a new 
vial was recorded as day one, and the day of next generation eclosing adults was recorded until 
day 20.  
 
Genotyping  
Flies were anesthetized using CO2 and visualized under a stereomicroscope using a Nightsea 
fluorescence adapter (https://www.nightsea.com). Green fluorescent protein (GFP) was 
visualized with 440–460 nm excitation light and 500–560 nm emission filter. Red fluorescent 
protein (RFP) was visualized with a 510–540nm excitation light source and a 600nm emission 
filter.  
 
Drosophila stocks and experimental crosses  
The haploinsufficient knockdown/rescue RPM-Drive D. melanogaster stock from [11] was 
generated by engineering 14 synonymous base pair changes in RpL14 to create a rescue that 
evaded knockdown by “hairpin” double-stranded RNAi. The phiC31 integration system was used 
to insert the construct, marked with RFP and w+mC (Flybase.org) into cytological position 86Fb 
on chromosome 3 (w+ phenotype = red eyes [dominant]; w- phenotype = white eyes [recessive]). 
[11, 41]. The RNAi is under the control of the GAL4/UAS binary expression system [11, 29]; the 
insert expresses GAL4 with a ubiquitously expressed Actin5C promoter (“GAL4” in figures and 
text) to express RNAi. This GAL4 is homozygous lethal, and is maintained by a classical second 
chromosome balancer chromosome (CyO, “Curly of Oster”, which is itself homozygous lethal 
and suppresses recombination with a series of overlapping inversions marked by Cy- (Cy- 
phenotype = curled wings [dominant]; Cy+ phenotype = straight wings [recessive]). Because both 
second chromosomes are recessive lethal, only offspring heterozygous at chromosome 2 (i.e., 
GAL4 / Cy-; Figure 1) survive each generation. Thus the entire construct has a built-in failsafe; in 
the event of an outcross to a wildtype second chromosome, the GAL4 is expected to be lost at a 
rate of at least p2 each generation, where p is the frequency of the promoter, thus rapidly 
inactivating RNAi knockdown and hence the RPM-Drive. For experimental crossing purposes, a 
comparison D. melanogaster line was also generated that was identical in genotype except for 
3xP3 driven GFP [42, 43] inserted into 86Fb rather than the RPM-Drive. This comparison stock 
functions as “wildtype”, since it does not contain RPM-Drive or modifications to any Rp gene 
expression (Figure 1). See [11] for complete details.  
 
Minimum cross starting numbers 
Reciprocal vials for each cross were set up with a minimum of two vials per cross (males 
from stock x and females from stock y or males from stock y and females from stock x). Each 
individual vial had an initial minimum of five freshly eclosed females and five freshly eclosed 
males. All data on offspring counts were pooled across vials for the same cross.  
 
Experiment 1: Evaluate RPM-Drive after 200+ generations (compare Rp dosage of one to 
two) 
We assessed the current activity of RPM-Drive in a fashion similar to how it was originally 
assessed by [11] (Figure 1). We initiated crosses of RPM-Drive / RPM-Drive homozygotes with 
the “wildtype” described in the previous paragraph (+ / +, in Figure 2; RPM-Drive initial 
frequency = 0.5). These homozygous stocks were termed F0; crosses were initiated on Day 1. F0 
females were allowed to lay eggs for one week, and then all adults were cleared. Newly 
emerging F1 adults were collected from each vial, scored for sex, RFP, and GFP, to confirm their 
genotype, and then allowed to lay eggs in a vial for 1 day before being transferred to a new vial. 
F2 offspring were collected upon eclosion, and scored for sex, RFP and GFP expression. In the 
absence of underdominance effects, the expected Mendelian ratio of genotypes for F2s is 1:2:1. 
 
Experiment 2: Compare Rp dosage of one to three 
The RPM-Drive / RPM-Drive stock was crossed to a homozygous white-eyed (w-) stock 
(Figure 3, panel A). The w- stock did not contain any of the RPM-Drive construct, so the 
hemizygous offspring would either inherit the GAL4 transactivator or the Cy- balancer 
chromosome (Figure 3, panels B and C). Offspring exhibiting the Cy- curled wing phenotype 
would have inactive RNAi and would not knockdown the endogenous RpL14. Thus, they would 
have two functional endogenous RpL14, plus one the RpL14-rescue (Figure 3, panel C; final Rp 
dosages of three). Offspring without the Cy- curled wing phenotype would have a final Rp 
dosage of one, from the RpL14-rescue (Figure 3, panel B). This cross mimics a disruption of the 
built-in GAL4 failsafe that would occur from an accidental release of individuals from the 
original RPM-Drive / RPM-Drive stock, whereby the gene drive system was predicted to quickly 
inactivate over the following generations due to independent assortment of the RPM-Drive away 
from the GAL4 system [11].  
 
Experiment 3: Compare Rp dosage of two to three  
Cy- offspring from Experiment 2 (Figure 3, panel C) were crossed to w- (Figure 3, panel A). 
This completely removed the GAL4 system from the cross so that final dosages of three Rps to 
two could be directly compared. Individuals expressing the additional Rp could be tracked by w+ 
or RPF (Figure 3, panels D and E). 
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Figure legends 
 
Figure 1: A simplified schematic of the underdominance system of [11]. The first, second, and 
third chromosomes of D. melanogaster are represented by horizontal lines from left to right. 
Arrows indicate transactivation. Lines ending in asterisks indicate mRNA knockdown by RNAi. 
Red and green fluorescent markers (RFP; GFP) used to track genotypes are indicated in their 
corresponding colors. Fully active Rps are indicated in blue.  A wildtype individual possesses 
two endogenous copies of the RpL14 gene, and therefore makes sufficient protein to grow and 
develop normally. A hemizygote (equivalent to a heterozygote in the theoretical underdominance 
literature [3, 5]) possesses the endogenous RpL14, along with the modified allele. As the 
modified allele contains the dominant knockdown system, RNAi reduces expression of all 
endogenous RpL14 protein. However, the modified allele also includes the RpL14-rescue, which 
produces the RpL14 protein. As the hemizygote contains only one haploinsufficient allele that 
can produce the RpL14 protein, its growth and development are delayed in a Minute-like fashion. 
In contrast, individuals that possess two modified alleles have two copies of the RpL14-rescue, 
and so are able to grow and develop at a rate much more similar to the wildtype individual. Thus, 
the hemizygote is less fit than either homozygote (i.e., underdominance). 
 
Figure 2: Results of Experiment 1, showing F2 counts. Left) counts of each genotype, showing 
an excess of homozygotes and deficiency of hemizygotes. Right) Cumulative day of eclosion 
showing the developmental delay of homozygotes (solid lines) relative to hemizygotes (dashed 
lines).  
 
Figure 3: Genotypes from Experiments 2 and 3. A)  Genotype of homozygous white-eyed flies 
used for crosses. B) Heterozygous F1 offspring genotypes possible from Experiment 2, which 
crossed homozygous white-eyed flies (Figure 3A) to homozygous RPM-Drive flies (Figure 1A). 
Experiment 2 tested the system in the absence of the second chromosome GAL4 transactivator. 
Single copy Rp expression (active hemizygote) was compared to triple copy Rp expression 
(inactive hemizygote). In this experiment, curled wings (i.e., Cy-) indicated the triple Rp copy, 
while straight wings indicated the single Rp copy. C) Heterozygous F1 offspring genotypes 
possible from Experiment 3, which crossed triple Rp copy flies (Figure 3C) to homozygous 
white-eyed flies (Figure 3A). Offspring with expression from three Rp copies were compared to 
flies with the wildtype level of Rp expression (two copies). In this experiment Rp dosage could 
be tracked with the presence or absence of w+ (i.e., red versus white eyes), or of RFP. Red eyes 
(w+) or RFP indicated three dosages, while white eyes (w-) indicated wildtype dosage. 
 
Figure 4A & B) Results of Experiment 2, showing F1 counts. A) Observed and expected counts 
are not significantly divergent. B) Offspring with active RNAi (blue) have delayed development, 
consistent with a Minute-like effect compared to inactive RNAi (red). The numbers in 
parentheses refer to the number of RpL14 copies evading RNAi knockdown. C & D) Results of 
Experiment 3. C) the engineered RpL14, marked with w+ is underrepresented in the offspring 
compared to an expected 1:1 ratio. D) There is no significant divergence in development time 
(Kolmogorov-Smirnov test, see text) in either males or females, associated with Rp 
overexpression. The numbers in parentheses refer to the number of RpL14 copies. Labels: “Cy-” 
= curly-winged; Cy+” = straight-winged; “w-” = white-eyed; “w+” = red-eyed. 
 
Figure 5: Predicted effects of RPM-Drive loss-of-function (LoF) mutations. A) RPM-Drive 
application. Note that for a hypothetical application in a species other than D. melanogaster the 
GAL4 transactivator would be removed, and the RNAi would be placed directly under an 
endogenous promoter, such as Actin. B) Mutations of the Rp-rescue result in haploinsufficiency, 
and are expected to be removed by selection. C) Mutations of the RNAi knockdown are expected 
to result in imbalanced Rp overproduction when homozygous, reducing organism fitness and 
resulting in removal of these mutations from the population. D) A deletion of the insert 
essentially returns the chromosome to a wildtype state, and is expected to be removed by 
selection when rare, because of haploinsufficiency (compare to Figure 1). E) Loss-of-function 
mutations of the endogenous Rp would possibly be neutral. F) Combinations of mutations can 
result in balanced Rp production; however, these are likely to be disrupted in the following 
generations when rare and removed by selection. 
 
Figure S1: Depiction of the relative fitness of individuals expressing various copies of a Rp. 
Zero expression is lethal and has the lowest relative fitness. Expression of two copies results in 
the highest, wildtype level of fitness. Expression of one copy results in an intermediate 
haploinsufficient Minute-like fitness. Expression of three (or presumably more) copies also 
results in an intermediate level of fitness. 
 
Table legends  
 
Table S1: Experiment 1 sex and genotype of F2 offspring versus day of adult eclosion. 
Table S2: Experiment 2 sex and genotype of F1 offspring versus day of adult eclosion. 
Table S3: Experiment 3 sex and genotype of F1 offspring versus day of adult eclosion. 
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Table S1 
Day RPM / RPM ♂ RPM / + ♂ +/+ ♂ RPM / RPM  ♀ RPM / + ♀ +/+ ♀ 
12 1   1  2 
13 10 3 16 7 9 20 
14 17 16 12 11 32 14 
15 6 7   3  
16  1   1   
17   1  2 1 
18 2 2   4  
Total 36 29 29 19 51 37 
 
Table S2 
Day Cy- ♂ Cy+ ♂ Cy- ♀ Cy+ ♀ 
11   1  
12 13 2 26 6 
13 55 34 51 43 
14 11 37 5 24 
15 1   2 
Total 80 73 83 75 
 
Table S3 
Day w- ♂ w- ♀ w+ ♂ w+ ♀ 
13 1   2 
14 20 14 16 16 
15 41 21 20 14 
16 10 8 9 5 
17 1 4 1 4 
Total 73 47 46 41 
 	
